page banner

Clinical Service

Full Cycle Cancer Management

By leveraging high-throughput sequencing technology and placing liquid biopsy at its core, HaploX offers a comprehensive range of clinical genetic testing solutions tailored to solid tumors, encompassing the entire cancer management cycle based on clinical requirements.

Pan-Cancer Genetic Testing Assays

Minimal Residual Disease (MRD) Detection Assays

海微清

HapOnco® mClear MRD Test

肺癌

HapOnco® Lung Cancer mClean MRD Test

消化道肿瘤

HapOnco® Gastrointestinal Cancer mClean MRD Test

肝胆胰肿瘤

HapOnco® Hepatobiliary and Pancreatic Cancer mClean MRD Test

Specific-Cancer Genetic Testing Assays

海普康系列

Lung Cancer

海普康系列

Gynecologic Cancer

海普康系列

Hepatobiliary and Pancreatic Cancer

海普康系列

Gastrointes­tinal Cancer

海普康系列

Breast Cancer

海普康系列

Urological Cancer

海普康系列

Central Nervous System Tumors

Service Commitments

Raw Data

Raw data is available for doctors and patients to conduct re-analysis.

Comprehensive
and Fast

Comprehensive assessment of tumor genetic information to guide clinical treatment, covering various sample types; testing reports are issued within 7 to 10 days upon collecting qualified samples.

Professional Interpretation

Professional medical and genetic teams interpret the report, striving to maximize clinical benefits.

Anti-counterfeiting
Report

Each report is issued with a unique anti-counterfeiting QR code to verify its authenticity.

Self-developed Algorithms

The LIUDUS® platform, developed through in-house patented software, machine learning models and internal data libraries, is applied throughout the entire NGS process, enabling ultra-sensitive variant detection and providing physicians and patients with reliable clinical information.

Top-notch Quality
Control

Our laboratories have passed over 133 NCCL tests and certified by CAP (U.S.), CLIA (U.S.) and EMQN (EU).
荣誉资质
荣誉资质
荣誉资质
荣誉资质
contact us

Your Privacy Choices

For research, user experience, and targeted advertising, our site uses technologies like cookies and scripts to collect your activity data, which may be shared with third parties in real time. You can choose to consent or decline via the buttons below.

Privacy Policy